Indian generic drugmaker Ranbaxy has struggled since its acquisition by Japan’s Daiichi Sanyko. Will the firm fare any better following its purchase by India’s Sun Pharmaceutical Industries?
- Mar 13, 2014
In collaboration with EY
- Feb 04, 2014
An EY/EIU survey shows that stronger global economic growth and expectations for more M&A deals in 2014 will likely spur more private equity activity.
In collaboration with Wipro
- Feb 03, 2014
Developing new products today involves a chain of daunting new challenges.